IATI Biomed 2015: Medasense Pain Monitor Among Winners Of Prestigious Startup CompetitionMay. 21, 2015
Understanding pain is still a major challenge for millions of doctors and patients around the world: How severe is a patient’s pain? Can the level of pain tell the physician something about the patient’s condition?
An Israeli biomed startup called Medasense has developed a technology that mathematically measures pain in order to give doctors the best assessments. And that’s why last week, the company was announced as one of two winners of the startup competition at the Israel Advanced Technology Industries (IATI) Biomed Conference.
Founded in 2008 by Galit Zuckerman, Medasense’s innovative technology assesses changes in a patient’s level of pain. The company’s flagship product is a non-invasive pain monitoring device that can help clinicians achieve better patient outcomes by accurately adjusting treatment.
Everyone knows that the sensation of pain is completely subjective, and doctors mostly rely on patients’ self-reports. “Pain is now widely considered the fifth vital sign, yet managing pain, especially in the surgical setting, remains a major challenge,” Medasense’s board member Dr. Daniel Sessler said in a statement. “Physicians currently rely on patients’ subjective assessments, or use their own judgment when patients cannot describe their pain. Medasense offers a new approach.”
The new approach involves developing an algorithm that mathematically measures pain. “Some people under anaesthesia remain awake yet paralyzed, not being able to communicate their pain”, Zuckerman tells NoCamels. That’s why it’s important to translate pain into numbers.
For the full feature story on NoCamels click here.